Verity Asset Management Inc. Has $284,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Verity Asset Management Inc. reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 561 shares of the healthcare conglomerate’s stock after selling 50 shares during the period. Verity Asset Management Inc.’s holdings in UnitedHealth Group were worth $284,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. AMF Tjanstepension AB increased its stake in UnitedHealth Group by 88.0% during the 3rd quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock worth $151,374,000 after acquiring an additional 121,180 shares during the period. Czech National Bank increased its stake in shares of UnitedHealth Group by 7.3% in the 3rd quarter. Czech National Bank now owns 188,110 shares of the healthcare conglomerate’s stock valued at $109,984,000 after purchasing an additional 12,721 shares during the last quarter. Hudson Value Partners LLC increased its stake in shares of UnitedHealth Group by 8.3% in the 3rd quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock valued at $625,000 after purchasing an additional 82 shares during the last quarter. Versant Capital Management Inc increased its stake in shares of UnitedHealth Group by 17.8% in the 3rd quarter. Versant Capital Management Inc now owns 1,011 shares of the healthcare conglomerate’s stock valued at $591,000 after purchasing an additional 153 shares during the last quarter. Finally, Ignite Planners LLC increased its stake in shares of UnitedHealth Group by 11.2% in the 3rd quarter. Ignite Planners LLC now owns 1,353 shares of the healthcare conglomerate’s stock valued at $791,000 after purchasing an additional 136 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Bank of America cut their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. KeyCorp reissued an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. UBS Group dropped their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Finally, Stephens increased their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $629.32.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.33% of the stock is owned by corporate insiders.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $545.08 on Wednesday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The business has a fifty day moving average price of $535.03 and a 200-day moving average price of $565.09. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market capitalization of $501.63 billion, a P/E ratio of 35.17, a PEG ratio of 1.48 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the company earned $5.83 earnings per share. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.63 EPS for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.